Health Condition 1: D249- Benign neoplasm of unspecified breast
Conditions
Interventions
Intervention1: Complex Decongestive therapy (CDT): The complex decongestive therapy is divided into 2 phases. They are as follows:
1.Volume reduction phase or intensive phase: comprised of manual lymp
Sponsors
Epshita kakati
Eligibility
Inclusion criteria
Inclusion criteria: 1. Females with unilateral mastectomy for stage I and II breast cancer. 2. Females who have undergone mastectomy 1-3 years prior. 3. Females who have finished treatment i.e chemotherapy, radiotherapy 4. Females diagnosed with breast cancer-associated lymphedema. 5. Female who has undergone breast cancer surgery and experiencing discomfort at the surgical site, swelling in the afflicted limb, and heaviness in the affected limb. 6. Female who has experienced lymphedema with an increase of more than 3 cm compared to the opposite extremity. 7. Ability to walk without assistance at least 100 meters and no contraindications for participating in aerobic exercises.
Exclusion criteria
Exclusion criteria: 1. Females diagnosed with metastatic breast cancer. 2. Female anticipating breast reconstruction within the next six months. 3. Women with any medical conditions that could hinder their ability to engage in exercise, such as decompensated heart failure, unstable ischemic heart disease, severe untreated hypertension, moderate to severe chronic obstructive pulmonary disease, aortic aneurysm, or chronic respiratory insufficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Universal Goniometer Hand-held dynamometer Anthropometric measurement using inch tape Micro Respiratory Pressure Meter Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| DASH questionnaire Timepoint: 4 weeks;DASS-21 questionnaireTimepoint: 4 weeks;Harvard Step testTimepoint: 4 weeks;WHOQOL- BREF questionnaireTimepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactEpshita kakati
SGT University
Outcome results
None listed